Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duyiwei capsule plus acupuncture for qi-stagnation and blood-stasis type cervical spondylosis
ChiCTR2400079452Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Shaanxi University of Chinese Medicine
- Start
- Jul 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of duyiwei in cervical osteoarthritis (2 arms), sponsored by Affiliated Hospital of Shaanxi University of Chinese Medicine. Primary endpoints: Visual analogue pain score and TCM symptom quantitative evaluation table. Started Jul 2023; status: recruiting.
02
Drugs
duyiwei
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on ChiCTR2400079452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079452.